Acute Myocardial InfarctionMIRON-NATIONALNCT06162039
National Landscape of Hemorrhagic Myocardial Infarction in the United States
An observational study of Acute Myocardial Infarction, run by Rohan Dharmakumar at 1 site in United States.
Trial summary
Registry analysis for prevalence of hemorrhagic myocardial infarction in the United States Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Acute Myocardial Infarction
- How many people
- 24,181 participants
- Where
- 1 siteUnited States
- Study dates
- 13 Dec 2023to 15 Mar 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: All STEMI who underwent primary coronary intervention and revascularisation
Who may be able to join
- Acute Myocardial Infarction - STEMI Primary PCI Availability of lab parameters and/or CMR
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
United States1 site
Medical Imaging Research Institute, Cardiovascular Imaging Research Center
Indianapolis, Indiana, 46202
About this study
Official title: Prevalence of Hemorrhagic Myocardial Infarction in the United States
Registry analysis for prevalence of hemorrhagic myocardial infarction in the United States
- Conditions
- Acute Myocardial Infarction
What is being measured
The primary outcome is the main question the study is designed to answer.
Statewise proportion of Hemorrhagic Myocardial Infarction in the United States
Prevalence of Hemorrhagic Myocardial Infarction
Measured: 10 years
Secondary outcomes (3)
Statewise proportion of Acute Heart Failure in Hemorrhagic Myocardial Infarction
Prevalence of Acute Heart Failure in Hemorrhagic Myocardial Infarction
Measured: 30 days
Statewise proportion of re-hospitalization in Hemorrhagic Myocardial Infarction
Prevalence of re-hospitalization in Hemorrhagic Myocardial Infarction
Measured: 30 days
Statewise proportion of arrhythmia in Hemorrhagic Myocardial Infarction
Prevalence of arrhythmia in Hemorrhagic Myocardial Infarction
Measured: 30 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Dec 2023
- Study start13 Dec 2023
- Primary completion15 Mar 2025
- Study completion15 Mar 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acute Myocardial InfarctionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 24,181 participants (actual)
Sponsor and investigators
- Lead sponsor
- Rohan Dharmakumar
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Rohan Dharmakumar, Indiana University
- Investigators
- Keyur P Vora, MD FACC, Principal investigator, Indiana University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06162039
- Sponsor's protocol ID
- 19978b
- Acronym
- MIRON-NATIONAL
- Status last verified
- Sep 2025
- First submitted
- 30 Nov 2023
- Last updated
- 8 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence of Hemorrhagic Myocardial Infarction in the United States
- ClinicalTrials.gov ID
- NCT06162039
- Acronym / sponsor ID
- MIRON-NATIONAL / 19978b
- Conditions
- Acute Myocardial Infarction
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 24,181 participants (actual)
- Lead sponsor
- Rohan DharmakumarUniversity, hospital or other
- Study start
- 13 Dec 2023 (actual)
- Primary completion
- 15 Mar 2025 (actual)
- Study completion
- 15 Mar 2025 (actual)
- First posted
- 8 Dec 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Registry analysis for prevalence of hemorrhagic myocardial infarction in the United States
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- All STEMI who underwent primary coronary intervention and revascularisation
Key inclusion criteria (1 listed)
- Acute Myocardial Infarction - STEMI Primary PCI Availability of lab parameters and/or CMR
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Statewise proportion of Hemorrhagic Myocardial Infarction in the United States
Time frame: 10 years
Prevalence of Hemorrhagic Myocardial Infarction
3 secondary outcomes
Statewise proportion of Acute Heart Failure in Hemorrhagic Myocardial Infarction
Time frame: 30 days
Statewise proportion of re-hospitalization in Hemorrhagic Myocardial Infarction
Time frame: 30 days
Statewise proportion of arrhythmia in Hemorrhagic Myocardial Infarction
Time frame: 30 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Sep 2025.
- Individual participant dataSharing planned: No
Related trials for Acute Myocardial Infarction
Not yet recruitingObservational study
Elicit Drugs in Myocardial Infarction
Young Patients With Acute Myocardial Infarction
Recruiting
CT Stress Myocardial Perfusion, Fractional Flow Reserve and Angiography in Patients With Stable Chest Pain Syndromes
Coronary Artery Disease, Chest Syndrome
RecruitingPhase 4
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome
Acute Coronary Syndromes, STEMI
Recruiting
Heart@Home Safety and Efficacy of Hospital-at-Home Care Versus Standard Hospitalization in Cardiac Patients
Myocardial Infarction, Myocarditis Acute
Enrolling by invitationPhase 3
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
Acute Myocardial Infarction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Keyur P Vora, MD FACC principal investigator
Indiana University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Acute Myocardial Infarction, run by Rohan Dharmakumar at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Statewise proportion of Hemorrhagic Myocardial Infarction in the United States (time frame: 10 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2025.